R&D Systems Inc. Tocris Bioscience Boston Biochem

Antiangiogenics

Antiantiogenic agents are compounds which prevent angiogenesis in vitro and/or in vivo. Angiogenesis inhibitors may be endogenous or synthetic; others are obtained from diet, for example resveratrol.

Antiangiogenic Products

Inhibitors
Cat.No.
Product Name / Activity
4664 Obtustatin
Potent and selective α1β1 inhibitor; antiangiogenic
4733 P005091
USP7 inhibitor; antiangiogenic
Other
Cat.No.
Product Name / Activity
4706 Borrelidin
Antiangiogenic; inhibits threonyl-tRNA synthetase
1495 Combretastatin A4
Antiangiogenic
1768 Fumagillin
Antiangiogenic
1629 Herbimycin A
Antiangiogenic. Inhibits Src family kinases and Hsp90
1461 Linomide
Immunomodulator with antiangiogenic properties
1807 2-Methoxyestradiol
Antiangiogenic and apoptotic agent
2710 OGT 2115
Antiangiogenic. Heparanase inhibitor
4744 P11
Potent antagonist of αvβ3-vitronectin interaction; antiangiogenic
2954 PX 12
Thioredoxin-1 inhibitor; attenuates HIF-1α
1418 Resveratrol
Cyclooxygenase inhbitor
0652 Thalidomide
Antiangiogenic. Inhibits TNF-α synthesis
1098 Tranilast
Antiangiogenic
3101 XRP44X
Antiangiogenic; microtubule depolymerization agent

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Guide

Request your free copy

Cancer Research Guide

Highlights over 350 products for cancer research. Request a copy or view PDF today.

divider line

VEGF Pathway & Anti-Angiogenic Therapy

Written by N. Ferrara & Y. Crawford

Angiogenesis Poster

A summary of antiangiogenic therapies targeting the VEGF pathway and the mechanisms of therapy resistance.

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

Tocris Events

Win a Kindle

11th Congress of the French Neuroscience Society

11th Congress of the French Neuroscience Society

May 21 - 24, 2013

Lyon, France

Booth Number: 32